MS MEDIC: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MS MEDIC
Largest movements
- Cash +€71,431
up €71,431 (+64.4%), from €110,989 to €182,420
mainly Net result for the year (+€38,690) and Provisions (+€26,083)
- Reserves +€29,891
new in 2025: €29,891
- Provisions +€26,083
up €26,083 (+79.3%), from €32,898 to €58,980
- Tax, wage and social debts +€11,579
up €11,579 (+48.8%), from €23,715 to €35,294
- Profit (loss) carried forward +€8,799
up €8,799 (+7.8%), from €112,324 to €121,123
- Contributions -€5,000
down €5,000 (-100.0%), from €5,000 to €0
- Financial charges +€41,549
up €41,549 (+1103.7%), from €3,765 to €45,314
- Gross operating margin +€31,475
up €31,475 (+31.5%), from €99,818 to €131,293
- Provisions -€6,815
down €6,815 (-20.7%), from €32,898 to €26,083
- Other operating charges -€2,968
down €2,968 (-80.1%), from €3,707 to €739
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €178,540 | €250,934 | +€72,394 | +40.5% |
| Fixed assets | 21/28 | €7,603 | €7,433 | -€170 | -2.2% |
| Tangible fixed assets | 22/27 | €4,973 | €4,803 | -€170 | -3.4% |
| Plant, machinery and equipment | 23 | €3,241 | €3,797 | +€556 | +17.2% |
| Furniture and vehicles | 24 | €1,732 | €1,006 | -€727 | -41.9% |
| Financial fixed assets | 28 | €2,630 | €2,630 | = | 0.0% |
| Current assets | 29/58 | €170,936 | €243,501 | +€72,565 | +42.5% |
| Amounts receivable within one year | 40/41 | - | €1,041 | +€1,041 | |
| Other amounts receivable | 41 | - | €1,041 | +€1,041 | |
| Cash at bank and in hand | 54/58 | €110,989 | €182,420 | +€71,431 | +64.4% |
| Deferred charges and accrued income | 490/1 | €59,947 | €60,040 | +€93 | +0.2% |
| Total equity and liabilities | 10/49 | €178,540 | €250,934 | +€72,394 | +40.5% |
| Equity | 10/15 | €117,324 | €151,014 | +€33,690 | +28.7% |
| Contributions | 10/11 | €5,000 | €0 | -€5,000 | -100.0% |
| Reserves | 13 | - | €29,891 | +€29,891 | |
| Tax-exempt reserves | 132 | - | €29,891 | +€29,891 | |
| Profit (loss) carried forward | 14 | €112,324 | €121,123 | +€8,799 | +7.8% |
| Provisions and deferred taxes | 16 | €32,898 | €58,980 | +€26,083 | +79.3% |
| Deferred taxes | 168 | €32,898 | €58,980 | +€26,083 | +79.3% |
| Amounts payable | 17/49 | €28,318 | €40,940 | +€12,622 | +44.6% |
| Amounts payable within one year | 42/48 | €28,318 | €40,940 | +€12,622 | +44.6% |
| Trade debts | 44 | €3,425 | €3,374 | -€51 | -1.5% |
| Suppliers | 440/4 | €3,425 | €3,374 | -€51 | -1.5% |
| Taxes, remuneration and social security | 45 | €23,715 | €35,294 | +€11,579 | +48.8% |
| Taxes | 450/3 | €23,715 | €35,294 | +€11,579 | +48.8% |
| Other amounts payable | 47/48 | €1,178 | €2,272 | +€1,094 | +92.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,151 | €1,788 | +€638 | +55.4% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €32,898 | €26,083 | -€6,815 | -20.7% |
| Other operating charges | 640/8 | €3,707 | €739 | -€2,968 | -80.1% |
| Gross operating margin | 9900 | €99,818 | €131,293 | +€31,475 | +31.5% |
| Operating profit (loss) | 9901 | €62,063 | €102,683 | +€40,620 | +65.4% |
| Financial income | 75/76B | €86 | €0 | -€86 | -100.0% |
| Recurring financial income | 75 | €86 | €0 | -€86 | -100.0% |
| Financial charges | 65/66B | €3,765 | €45,314 | +€41,549 | +1103.7% |
| Recurring financial charges | 65 | €3,765 | €45,314 | +€41,549 | +1103.7% |
| Profit (loss) for the period before taxes | 9903 | €58,385 | €57,369 | -€1,016 | -1.7% |
| Income taxes | 67/77 | €19,215 | €18,679 | -€537 | -2.8% |
| Profit (loss) for the period | 9904 | €39,169 | €38,690 | -€479 | -1.2% |
| Transfer to tax-exempt reserves | 689 | - | €29,891 | +€29,891 | |
| Profit (loss) for the period to be appropriated | 9905 | €39,169 | €8,799 | -€30,370 | -77.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.